Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Shares Bought by Wasatch Advisors LP

Wasatch Advisors LP grew its holdings in shares of Nature’s Sunshine Products, Inc. (NASDAQ:NATR) by 23.2% during the 3rd quarter, HoldingsChannel reports. The firm owned 696,184 shares of the company’s stock after buying an additional 131,174 shares during the period. Wasatch Advisors LP’s holdings in Nature’s Sunshine Products were worth $9,482,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Gladius Capital Management LP boosted its stake in Nature’s Sunshine Products by 23.9% during the 2nd quarter. Gladius Capital Management LP now owns 6,862 shares of the company’s stock worth $103,000 after purchasing an additional 1,325 shares during the last quarter. Lazard Asset Management LLC boosted its stake in Nature’s Sunshine Products by 16.5% during the 1st quarter. Lazard Asset Management LLC now owns 7,040 shares of the company’s stock worth $146,000 after purchasing an additional 998 shares during the last quarter. XTX Topco Ltd acquired a new stake in Nature’s Sunshine Products during the 2nd quarter worth $180,000. Bailard Inc. acquired a new stake in Nature’s Sunshine Products during the 2nd quarter worth $197,000. Finally, Bank of New York Mellon Corp boosted its stake in Nature’s Sunshine Products by 12.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 48,589 shares of the company’s stock worth $732,000 after purchasing an additional 5,425 shares during the last quarter. Institutional investors and hedge funds own 79.40% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. Canaccord Genuity Group initiated coverage on shares of Nature’s Sunshine Products in a research note on Friday, September 13th. They set a “buy” rating and a $18.00 target price on the stock. DA Davidson lowered their price target on shares of Nature’s Sunshine Products from $23.00 to $21.00 and set a “buy” rating on the stock in a research report on Monday, August 12th. Canaccord Genuity Group initiated coverage on shares of Nature’s Sunshine Products in a research report on Friday, September 13th. They set a “buy” rating and a $18.00 price target on the stock. Finally, StockNews.com raised shares of Nature’s Sunshine Products from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, September 10th.

Insider Activity at Nature’s Sunshine Products

In related news, major shareholder Fosun Pharmaceutical Shanghai sold 3,000 shares of the business’s stock in a transaction dated Thursday, October 10th. The shares were sold at an average price of $13.39, for a total value of $40,170.00. Following the sale, the insider now directly owns 69,347 shares in the company, valued at approximately $928,556.33. The trade was a 4.15 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In the last ninety days, insiders have sold 7,499 shares of company stock worth $99,802. Company insiders own 4.70% of the company’s stock.

Nature’s Sunshine Products Trading Up 0.6 %

Shares of NATR stock opened at $16.24 on Friday. The company’s 50-day moving average price is $14.15 and its 200-day moving average price is $14.51. The stock has a market cap of $300.05 million, a price-to-earnings ratio of 18.45 and a beta of 0.87. Nature’s Sunshine Products, Inc. has a twelve month low of $10.81 and a twelve month high of $21.72.

Nature’s Sunshine Products Profile

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.